Abstract:Calcineurin is a calcium/calmodulin-regulated phosphatase known for its role in activation of T cells following engagement of the T cell receptor. Calcineurin inhibitors (CNIs) are widely used as immunosuppressive agents; common adverse effects of CNIs are hypertension and hyperkalemia. While previous studies have implicated activation of the Na-Cl cotransporter (NCC) in the renal distal convoluted tubule (DCT) in this toxicity, the molecular mechanism of this effect is unknown. The renal effects of CNIs mimic the hypertension and hyperkalemia that result from germ-line mutations in with-no-lysine (WNK) kinases and the Kelch-like 3 (KLHL3)-CUL3 ubiquitin ligase complex. WNK4 is an activator of NCC and is degraded by binding to KLHL3 followed by WNK4's ubiquitylation and proteasomal degradation. This binding is prevented by phosphorylation of KLHL3 at serine 433 (KLHL3S433-P) via protein kinase C, resulting in increased WNK4 levels and increased NCC activity. Mechanisms mediating KLHL3S433-P dephosphorylation have heretofore been unknown. We now demonstrate that calcineurin expressed in DCT is a potent KLHL3S433-P phosphatase. In mammalian cells, the calcium ionophore ionomycin, a calcineurin activator, reduces KLHL3S433-P levels, and this effect is reversed by the calcineurin inhibitor tacrolimus and by siRNA-mediated knockdown of calcineurin. In vivo, tacrolimus increases levels of KLHL3S433-P, resulting in increased levels of WNK4, phosphorylated SPAK, and NCC. Moreover, tacrolimus attenuates KLHL3-mediated WNK4 ubiquitylation and degradation, while this effect is absent in KLHL3 with S433A substitution. Additionally, increased extracellular K+ induced calcineurin-dependent dephosphorylation of KLHL3S433-P These findings demonstrate that KLHL3S433-P is a calcineurin substrate and implicate increased KLHL3 phosphorylation in tacrolimus-induced pathologies.

A novel calcineurin splice variant that modifies calcineurin activity: Calcineurin splice variant

A Novel Splice Variant of Gαq-coupled Bombyx CAPA-PVK Receptor 1 Functions As a Specific Gαi/o-linked Receptor for CAPA-PK.

Smooth Muscle Tissues Express a Major Dominant Negative Splice Variant of the Type 3 Ca2+ Release Channel (ryanodine Receptor).

Cellular And Molecular Consequences Of Calcineurin A Alpha Gene Deletion

Splice variants of CK1α and CK1α-like: Comparative analysis of subcellular localization, kinase activity, and function in the Wnt signaling pathway

Functional analysis of CASK transcript variants expressed in human brain

Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

CaMKIIδ Splice Variants in the Healthy and Diseased Heart

Calcineurin Dephosphorylates Kelch-like 3, Reversing Phosphorylation by Angiotensin II and Regulating Renal Electrolyte Handling.

The Interplay Between Splicing of Two Exon Combinations Differentially Affects Membrane Targeting and Function of Human CaV2.2

Splice-variant-specific Effects of Primary Aldosteronism Point Mutations on Human CaV3.2 Calcium Channels.

Analysis of splice variants for the C. elegans orthologue of human neuroligin reveals a developmentally regulated transcript

Splice Variant of Spalax Heparanase Skipping Exon 12

Branch point strength controls species-specific CAMK2B alternative splicing and regulates LTP

A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks

Lamb2 Novel Variant C.2885-9 C > A Affects Rna Splicing In A Minigene Assay

Alternative splice isoforms of small conductance calcium-activated SK2 channels differ in molecular interactions and surface levels

Calcineurin is an adaptor required for assembly of the TCR signaling complex

Silencing calcineurin A subunit reduces SERCA2 expression in cardiac myocytes

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin